For patients who experience endoscopic remission of ulcerative colitis (UC), signs of active disease on histology did not affect their risk of clinical relapse, according to a large prospective study ...

People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Low-grade dysplasia (LGD)—abnormal ...

An AI workflow accurately grouped ulcerative colitis‑LGD patients by cancer risk, flagging about half as low‑risk with a ~99 % chance of staying cancer‑free for two years. The AI workflow revealed ...

Executives from Equillium (NASDAQ:EQ) outlined the scientific rationale and near-term development plans for its lead program, EQ504, during a recent fireside chat focused on immunology and ...

A novel study using a mouse model has found that the absence of the angiopoietin-like 4 (ANGPTL4) protein during development ...

Potential to become a new modality in the treatment of ulcerative colitis offering prolonged remission without immune suppressionThe study which compared MB310, a precision microbiome medicine, with ...

The AISight® Clinical Trials Platform provides a robust, GCP/GCLP-compliant environment that bridges the gap between traditional pathology and computational precision. By launching these tools on ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information by sharing relevant background and reasoning ...

Lymphocytic colitis is a type of microscopic colitis that causes persistent, watery diarrhea. Experts still do not know the exact underlying cause. Microscopic colitis involves inflammation of the ...